
Joel Armotrading
GTD
Injury Chest
2025 CBB Stats
PTS
6.1
REB
5.1
AST
0.4
STL
0.4
BLK
1.3
ROS Projections
Out once again
Armotrading (chest) is out for Friday's game against UNLV, according to Nevada Sports Net.
ANALYSIS
Another game, another absence for Armotrading, who hasn't played since Nov. 27 for Nevada. It's unclear when he'll be able to play again, but his next chance to do so will come in a matchup against Boise State on Tuesday, Feb. 3.
Another game, another absence for Armotrading, who hasn't played since Nov. 27 for Nevada. It's unclear when he'll be able to play again, but his next chance to do so will come in a matchup against Boise State on Tuesday, Feb. 3.
College Basketball Stats
Loading CBB Stats...
2023 CBB Game Log
2025
2024
2023
2025 CBB Game Log
Loading Game Log...
2025 CBB Split Stats
Loading CBB Stats...
Wolf Pack Depth Chart
Our full team depth charts are reserved for RotoWire subscribers.
Subscribe Now
More Fantasy News
Deemed questionable
Armotrading (chest) is questionable for Friday's game versus UNLV.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Inactive Wednesday
Armotrading (chest) will not appear in Wednesday's game against Utah State.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Undergoes medical imaging
Armotrading (chest) underwent medical imaging Tuesday, according to Dominic Gutierrez of SB Nation.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Given questionable tag again
Armotrading (chest) is questionable for Tuesday's game against San Diego State.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.
Doesn't play Saturday
Armotrading (chest) didn't play Saturday against Fresno State.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.

